ArticleDiabetes care2020
Predicting 5- and 10-Year Mortality Risk in Older Adults With Diabetes.
Article in Diabetes care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 48 citations in OpenAlex.
- Haemoglobin A1c Time-In-Range and Mortality in Adults With Diabetes.Endocrinology, diabetes & metabolism · 2026Article
- Article
- Development of Age- and Sex-Specific Metabolomics-Based Biological Ageing Clocks for 10-Year Mortality Prediction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- 13. Older Adults: Standards of Care in Diabetes-2026.Diabetes care · 2026Review
- Hemoglobin A1c time-in-range, mortality, and diabetes complications in older adults with diabetes.BMJ open diabetes research & care · 2025Observational
- Classification rule for ten year MACE Risk in primary care tarragona older adults with type2 diabetes: a CHAID decision-tree analysis.BMC primary care · 2025Article
- Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure.International journal of cardiology · 2025Article
- 13. Older Adults: Standards of Care in Diabetes-2025.Diabetes care · 2025Review
- Glycated Hemoglobin A1c Time in Range and Dementia in Older Adults With Diabetes.JAMA network open · 2024Article
- Holistic and Personalized Strategies for Managing in Elderly Type 2 Diabetes Patients.Diabetes & metabolism journal · 2024Review
- Hospital Readmissions in Patients Supported with Durable Centrifugal-Flow Left Ventricular Assist Devices.Journal of clinical medicine · 2024Article
- 13. Older Adults: Standards of Care in Diabetes-2024.Diabetes care · 2024Review
- Development and Validation of the Life Expectancy Estimator for Older Adults with Diabetes (LEAD): the Diabetes and Aging Study.Journal of general internal medicine · 2023Article
- Survival Prediction in Diabetic Foot Ulcers: A Machine Learning Approach.Journal of clinical medicine · 2023Article
- The Growing Role of Technology in the Care of Older Adults With Diabetes.Diabetes care · 2023Review
- Prognostic models for short-term annual risk of severe complications and mortality in patients living with type 2 diabetes using a national medical claim database.Diabetology & metabolic syndrome · 2023Article
- Association of hemoglobin A1c stability with mortality and diabetes complications in older adults with diabetes.BMJ open diabetes research & care · 2023Observational
- Development and economic assessment of machine learning models to predict glycosylated hemoglobin in type 2 diabetes.Frontiers in pharmacology · 2023Article
- Prevalence and trend of atrial fibrillation and its associated risk factors among the population from nationwide health check-up centers in China, 2012-2017.Frontiers in cardiovascular medicine · 2023Article
- 13. Older Adults: Standards of Care in Diabetes-2023.Diabetes care · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
objectiveSeveral diabetes clinical practice guidelines suggest that treatment goals may be modified in older adults on the basis of comorbidities, complications, and life expectancy. The long-term benefits of treatment intensification may not outweigh short-term risks for patients with limited life expectancy. Because of the uncertainty of determining life expectancy for individual patients, we sought to develop and validate prognostic indices for mortality in older adults with diabetes. RESEARCH DESIGN AND
methodsWe used a prevalence sample of veterans with diabetes who were aged ≥65 years on 1 January 2006 (
resultsThirty-seven predictors of mortality were identified: 4 demographic variables, prescriptions for insulin or sulfonylureas or blood pressure medications, 6 biomarkers, previous outpatient and inpatient utilization, and 22 comorbidities/procedures. The prognostic indices showed good discrimination, with C-statistics of 0.74 and 0.76 for 5- and 10-year mortality, respectively. The indices also demonstrated excellent agreement between observed outcome and predictions, with calibration slopes of 1.01 for both 5- and 10-year mortality.
conclusionsPrognostic indices obtained from administrative data can predict 5- and 10-year mortality in older adults with diabetes. Such a tool may enable clinicians and patients to develop individualized treatment goals that balance risks and benefits of treatment intensification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.